ENTITY
Voronoi

Voronoi (310210 KS)

12
Analysis
Health CareSouth Korea
Voronoi, Inc. operates as a drugs development company. The Company develops and manufactures kinase inhibitor and other new drugs. Voronoi provides services in Korea.
more
bullishLunit
04 Sep 2023 06:10

KOSDAQ150 Index Rebalance Preview: Strong Momentum Leads to Outperformance

There could be 14 changes for the KOSDAQ150 in Dec. There could be changes even prior to Dec due to delistings/section transfers. Momentum in Korea...

Logo
494 Views
Share
bullishHDFC Bank
02 Jul 2023 06:09

Index Rebalance & ETF Flow Recap: KQ150, LQ45, PCOMP, HDFC/HDFCB, Delta Electronics, Redox IPO, AMFI

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
405 Views
Share
bearishBionote
31 May 2023 17:02

End of Mandatory Lock-Up Periods for 45 Companies in Korea in June 2023

We discuss the end of the mandatory lock-up periods for 45 stocks in Korea in June 2023, among which 6 are in KOSPI and 39 are in KOSDAQ.

Logo
326 Views
Share
31 Aug 2022 14:24

End of Mandatory Lock-Up Periods for 40 Companies in Korea in September 2022

We discuss end of the mandatory lock-up periods for 40 stocks in Korea in September 2022. These 40 stocks on average could be subject to further...

Logo
243 Views
Share
01 Jul 2022 02:31

End of Mandatory Lock-Up Periods for 40 Companies in Korea in July 2022

We discuss end of the mandatory lock-up periods for 40 stocks in Korea in July 2022.Among these 40 stocks, LG Energy Solution could face further...

Logo
508 Views
Share
x